Application of Luteolin in Neoplasms and Nonneoplastic Diseases.

Int J Mol Sci · 2023 · PMC10650338 · PMID 37958980

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

The described studies prove that luteolin clinical application in the role of a chemotherapeutics enhancer might be significantly effective.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.